# HYPNAYA Feasibility Study

> **NCT06021093** · — · UNKNOWN · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 30 (estimated)

## Conditions studied

- AYA Cancer Patients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06021093
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-17
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06021093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06021093, "HYPNAYA Feasibility Study". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT06021093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*